Data / Form D filings / NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc.: Form D filings
NeuBase Therapeutics, Inc., a biotechnology company in Pittsburgh, PA, filed 7 Form D notices with the SEC between 2009 and 2023. The latest, on July 7, 2023, reports $5 million sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 350 TECHNOLOGY DRIVE, Pittsburgh, PA, 15219
- Phone
- (412) 763-3350
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1173281
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 7, 2023 | New notice | $5,000,002 | $5,000,002 | 1 | Jun 28, 2023 | sec.gov | |
| Dec 29, 2014 | New notice | $50,000 | $50,000 | 1 | Dec 24, 2014 | sec.gov | |
| Jun 4, 2014 | New notice | $25,180,224 | $10,180,224 | $15,000,000 | 1 | May 30, 2014 | sec.gov |
| Jan 16, 2014 | New notice | $569,581 | $569,581 | 3 | Dec 30, 2013 | sec.gov | |
| Oct 11, 2013 | New notice | $376,915 | $376,915 | 3 | Oct 2, 2013 | sec.gov | |
| Jun 4, 2009 | New notice | $1,080,000 | $1,005,000 | $75,000 | 24 | Jun 3, 2009 | sec.gov |
| Apr 3, 2009 | New notice | $500,000 | $500,000 | 1 | Mar 19, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eric Richman | Director | |
| Todd Branning | Executive Officer | |
| Dietrich Stephan | Executive Officer, Director | |
| Franklyn Prendergast | Director | |
| Gerald McDougall | Director | |
| Dov Goldstein | Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Jul 3, 2023 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NeuBase Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.